Status:
COMPLETED
Honey & Nigella Sativa Trial Against COVID-19
Lead Sponsor:
Sohaib Ashraf
Conditions:
Coronavirus Infection
Sars-CoV2
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
To evaluate the effectiveness of Nigella Sativa and honey stirred in 250 ml of distilled water 12 hourly till patient becomes asymptomatic or a maximum of 14 days with standard hospital care versus st...
Detailed Description
This cohort, adaptive, randomized, double armed group, controlled, Investigator Initiated interventional study is designed to demonstrate the superiority of a combination of black cumin with honey ove...
Eligibility Criteria
Inclusion
- Confirmed SARS-CoV-2 (COVID-19) infection by a positive test result with SSC-2 score\> 5
- Patients admitted in Corona centers
Exclusion
- Participants not giving consent.
- Pregnant and lactating females.
- History of allergy to any drug being administered in this study
- Severely terminally ill patients
- Patients on Nil Per Oral
Key Trial Info
Start Date :
April 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2020
Estimated Enrollment :
313 Patients enrolled
Trial Details
Trial ID
NCT04347382
Start Date
April 30 2020
End Date
August 30 2020
Last Update
November 12 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Federal Post-Graduate Medical Institute, Shaikh Zayed Hospital
Lahore, Punjab Province, Pakistan, 54600
2
Services Institute of Medical Sciences, Services Hospital
Lahore, Punjab Province, Pakistan, 54600